A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib

Clinical trial NCT07144111 · RECRUITING

Trial details

NCT number: NCT07144111
Sponsor: Genentech, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2025-08-21
Primary completion: 2026-09-04
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.